Cargando…

Extra energy for hearts with a genetic defect: ENERGY trial

AIMS: Previous studies have shown that hypertrophic cardiomyopathy mutation carriers have a decreased myocardial energy efficiency, which is thought to play a key role in the pathomechanism of hypertrophic cardiomyopathy (HCM). The ENERGY trial aims to determine whether metabolic drugs correct decre...

Descripción completa

Detalles Bibliográficos
Autores principales: van Driel, B. O., van Rossum, A. C., Michels, M., Huurman, R., van der Velden, J.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Bohn Stafleu van Loghum 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6439046/
https://www.ncbi.nlm.nih.gov/pubmed/30767167
http://dx.doi.org/10.1007/s12471-019-1239-0